Patent ID: 9575072
Date: 2017-02-21
CPC Classifications: A61K,A61P,C07K,C12Q,G01N,Y02A

Claim:
1. A method for evaluating the efficacy of a therapy in a chronic renal failure subject, the method comprising: (i) determining a level of plasma gelsolin from the subject, (ii) comparing the level of plasma gelsolin from the subject to a predetermined value of about 150 ng of gelsolin/μl of plasma, (iii) determining whether the level of plasma gelsolin is at or above the predetermined value, said determination indicating that the therapy is efficacious; and (iv) continuing the therapy in the subject having a level of plasma gelsolin at or above the predetermined value, or discontinuing or changing the therapy in the subject having a level of plasma gelsolin below the predetermined value.